Cargando…
Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice
Every year 170,000 patients are diagnosed with brain metastases (BMs) in the United States. Traditionally, adjuvant whole brain radiotherapy (AWBRT) has been offered following local therapy with neurosurgery (NSx) and/or stereotactic radiosurgery (SRS) to BMs. The aim is to increase intracranial con...
Autores principales: | Fogarty, Gerald B., Hong, Angela, Gondi, Vinai, Burmeister, Bryan, Jacobsen, Kari, Lo, Serigne, Paton, Elizabeth, Shivalingam, Brindha, Thompson, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930567/ https://www.ncbi.nlm.nih.gov/pubmed/27370683 http://dx.doi.org/10.1186/s12885-016-2433-8 |
Ejemplares similares
-
Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible
por: Fogarty, Gerald B, et al.
Publicado: (2014) -
Women's liberation and the rhetoric of "choice" in infant feeding debates
por: Hausman, Bernice L
Publicado: (2008) -
Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases
por: Le Scodan, Romuald, et al.
Publicado: (2010) -
Reframing a debate in chiropractic
por: Pollard, Henry
Publicado: (2021) -
Safety of topical thrombins: the ongoing debate
por: Lomax, Christopher
Publicado: (2009)